Welcome members and clients of OMMP PIF. Due to increased costs, our website has moved to this server, Thanks go to our Friend and colleague, Wired57, for making this possible. If you have any questions or concerns, please start a new topic in 
Thank you 
ALS clinical trails and search. ![[Image: ct.gov-logo.png]](http://www.clinicaltrials.gov/ct2/html/ct3/images/ct.gov-logo.png)
NEALS Researcher Receives Award for ALS Research
http://www.alsconsortium.org/news_neals_..._award.php
March 25, 2013
FOR IMMEDIATE RELEASE, MARCH 25, 2013
Boston Researcher Receives $240,000 Award for ALS Research Funded by American Brain Foundation and ALS Association
SAN DIEGO A Massachusetts researcher will receive $240,000 to continue his research on immune system changes in amyotrophic lateral sclerosis (ALS) through the Richard Olney, MD, Clinician-Scientist Development Three-Year Award funded by The American Brain Foundation and The ALS Association. The award was presented in San Diego during the American Academy of Neurologys 65th Annual Meeting, the worlds largest meeting of neurologists.
ALS
Cannabinol delays symptom onset
http://www.ncbi.nlm.nih.gov/sites/e...t_uids=16183560
Marijuana in the management of amyotrophic lateral sclerosis
http://www.medscape.com/medline/abstract/11467101
Cannabis use in patients with amyotrophic lateral sclerosis.
http://www.medscape.com/medline/abstract/15055508
Cannabis Relieves Lou Gehrigs Symptoms
http://www.rense.com/general51/lou.htm
Cannabis' Potential Exciting Researchers in Treatment of ALS, Parkinson's Disease
http://66.218.69.11/search/cache?ei...&icp=1&.intl=us
James D. Berry, MD, MPH, a researcher at the Massachusetts General Hospital and instructor at Harvard Medical School, received this award for his investigation of cells in the immune system that could potentially be used as a blood test for ALS. This award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies. The three-year award will consist of an annual salary of $75,000, plus $5,000 per year in educational expenses.
ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Affecting 30,000 Americans, its cause is unknown, there is no specific test for diagnosis, and there is no cure.
Clinical research is the fundamental transition stage between discovery and treatment. Clinical research provides the scientific basis for all forms of care, addresses patient and caregiver needs and is the backbone for drug development and cost-effectiveness studies needed to improve lives. Fellowships provide recipients with up to three years of protected time, with salary that allows them to continue important research projects.
NEALS Researcher Receives Award for ALS Research
http://www.alsconsortium.org/news_neals_..._award.php
March 25, 2013
FOR IMMEDIATE RELEASE, MARCH 25, 2013
Boston Researcher Receives $240,000 Award for ALS Research Funded by American Brain Foundation and ALS Association
SAN DIEGO A Massachusetts researcher will receive $240,000 to continue his research on immune system changes in amyotrophic lateral sclerosis (ALS) through the Richard Olney, MD, Clinician-Scientist Development Three-Year Award funded by The American Brain Foundation and The ALS Association. The award was presented in San Diego during the American Academy of Neurologys 65th Annual Meeting, the worlds largest meeting of neurologists.
ALS
Cannabinol delays symptom onset
http://www.ncbi.nlm.nih.gov/sites/e...t_uids=16183560
Marijuana in the management of amyotrophic lateral sclerosis
http://www.medscape.com/medline/abstract/11467101
Cannabis use in patients with amyotrophic lateral sclerosis.
http://www.medscape.com/medline/abstract/15055508
Cannabis Relieves Lou Gehrigs Symptoms
http://www.rense.com/general51/lou.htm
Cannabis' Potential Exciting Researchers in Treatment of ALS, Parkinson's Disease
http://66.218.69.11/search/cache?ei...&icp=1&.intl=us
James D. Berry, MD, MPH, a researcher at the Massachusetts General Hospital and instructor at Harvard Medical School, received this award for his investigation of cells in the immune system that could potentially be used as a blood test for ALS. This award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies. The three-year award will consist of an annual salary of $75,000, plus $5,000 per year in educational expenses.
ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Affecting 30,000 Americans, its cause is unknown, there is no specific test for diagnosis, and there is no cure.
Clinical research is the fundamental transition stage between discovery and treatment. Clinical research provides the scientific basis for all forms of care, addresses patient and caregiver needs and is the backbone for drug development and cost-effectiveness studies needed to improve lives. Fellowships provide recipients with up to three years of protected time, with salary that allows them to continue important research projects.